Jodar Luis
Jodar Luis, CMO, reported a transaction classified as grant at Vaxcyte, Inc. involving 52632.000000 shares for an estimated $0.00. Reported holdings after the transaction were 52632.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 04, 2026
- Filing date
- Sep 09, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
PCVX price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0002151661-26-000004 Common Stock
- Transaction date
- Sep 04, 2026 Filed Sep 09, 2026, 09:40 PM · 5d delay
- Shares
- 52,632 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 52,632 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-16 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - grant_or_award-22 points
transaction_code = A
Grant or award transactions are scheduled compensation, not discretionary.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Medical Officer
- F1
Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as…
to 1/4 of the shares subject to the award on September 7, 2027 and 1/8 of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such dat…
- F2
1/4 of the shares subject to the option shall vest on August 31, 2027, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through ea…
0 other transactions
0 recent txs